Sujal Shah serves as an Executive Officer at Juvia I Coinvest. See sector focus and contact routes.
Sujal Shah serves as an Executive Officer at Juvia I Coinvest A. His professional focus extends to the biopharmaceutical sector, where he is associated with Tvardi Therapeutics. This clinical-stage company is dedicated to advancing healthcare through the development of innovative oral small molecule therapies. Tvardi Therapeutics' research and development efforts are specifically concentrated on targeting STAT3, a key pathway implicated in various inflammatory and proliferative diseases. Through his involvement, Sujal Shah contributes to the strategic direction and operational oversight within Juvia I Coinvest A, while also maintaining a connection to the cutting-edge scientific advancements pursued by Tvardi Therapeutics in addressing significant medical needs.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Sujal Shah · Full investor directory · Investor access · Company funding database